Enlon-Plus Alternatives Compared
| Enlon-Plus (atropine / edrophonium) | Pyridostigmine | Sugammadex |
|
|---|
| Enlon-Plus (atropine / edrophonium) | Pyridostigmine | Sugammadex |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Reversal of Nondepolarizing Muscle Relaxants. Enlon-Plus may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myasthenia Gravis, Dysautonomia, Nerve Agent Pretreatment, Reversal of Nondepolarizing Muscle Relaxants. Pyridostigmine may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Reversal of Nondepolarizing Muscle Relaxants, Reversal of Neuromuscular Blockade. Sugammadex may also be used for purposes not listed in this medication guide. |
Related suggestions Reversal of Nondepolarizing Muscle Relaxants
|
|||||||
| More about Pyridostigmine | More about Sugammadex | |||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Pyridostigmine has an average rating of 7.2 out of 10 from a total of 59 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
Sugammadex has an average rating of 5.5 out of 10 from a total of 2 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Pyridostigmine side effects |
View all Sugammadex side effects |
|||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Pyridostigmine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
Mestinon, Mestinon Timespan, Regonol | Bridion | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
4.3 hours |
N/A |
2 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 273 drugs are known to interact with Enlon-Plus:
|
A total of 102 drugs are known to interact with Pyridostigmine:
|
A total of 28 drugs are known to interact with Sugammadex:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
|
||||||||||
| First Approval Date | ||||||||||
|
N/A |
April 06, 1955 |
December 15, 2015 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
|
N/A |
||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.